Device Proarrhythmia

  • Stephen Pavia
  • Sergio L. Pinski
  • Andrea Natale
Part of the Developments in Cardiovascular Medicine book series (DICM, volume 244)


The implantable cardioverter-defibrillator (ICD) is remarkably effective in detecting and terminating ventricular tachycardia (VT) and ventricular fibrillation (VF), and in improving survival in high-risk patients. However, rhythm-related complications and adverse events still occur, representing a source of patient morbidity and a clinical challenge to the physician. These adverse effects can result from system malfunction, intrinsic limitations of the detection and treatment algorithms or, more often, programming that is not optimally tailored to the patient. Here, we discuss pacing malfunction, spurious shocks, multiple appropriate and inappropriate activation, failure to deliver therapy, ineffective therapy, and device-induced proarrhythmia.


Ventricular Tachycardia Ventricular Pace Implantable Defibrillator Pace Threshold Inappropriate Shock 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Pinski SL, Trohman RG. Permanent pacing via implantable defibrillators. Pacing Clin Electrophysiol 2000;23:1758–1761PubMedGoogle Scholar
  2. 2.
    Gupta A, Zegel HG, Dravid VS, Nierenberg SJ, Freiman DB. Value of radiography In diagnosing complications of cardioverter defibrillators implanted without thoracotomy in 437 patients. AJR Am J Roentgenol 1997; 168:105–108PubMedGoogle Scholar
  3. 3.
    Irnich W. Implantable defibrillators and electromagnetic interference. Pacing ClinElectrophysiol 1999;22:981–982Google Scholar
  4. 4.
    Reiter MJ, Mann DE. Sensing and tachyarrhythmia detection problems in implantable cardioverter defibrillators. J Cardiovasc Electrophysiol 1996;7:542–558PubMedGoogle Scholar
  5. 5.
    Pinski SL. Inappropriate pacing due to autoperpetuation of the ventricular rate stabilization algorithm: a manifestation of T-wave oversensing by ICDs. Pacing Clin Electrophysiol 2000;23:1446–1447PubMedGoogle Scholar
  6. 6.
    Mann DE, Damle RS, Kelly PA, Landers M, Otto L, Reiter MJ. Comparison of oversensing during bradycardia pacing in two types of implantable cardioverterdefibrillator systems. Am Heart J 1998;136:658–663PubMedGoogle Scholar
  7. 7.
    Kopp DE, Lin AC, Burke MC, et al. Adverse events with dual-chamber implantable cardioverter-defibrillators. Pacing Clin Electrophysiol 1999;22:896 (Abstract)Google Scholar
  8. 8.
    GEM II DR system reference guide. Medtronic, Inc., Minneapolis, MN, 1999, p B-8Google Scholar
  9. 9.
    Pinski SL, Haw J, Trohman RG. Usefulness of a dynamic post-pace ventricular blanking period in dual-chamber, rate-responsive implantable defibrillators. Pacing Clin Electrophysiol 1999; 22:897 (Abstract)Google Scholar
  10. 10.
    Moore S, Edel T, Higgins SL, et al. A randomized controlled clinical trial comparing VF detection between the Ventak AV II DR and the Ventak AV. Pacing Clin Electrophysiol 1998;21:847 (Abstract)Google Scholar
  11. 11.
    Perry GY, Kosar EM. Problems in managing patients with long QT syndrome and Implantable cardioverter-defibrillators: a report of two cases. Pacing Clin Electrophysiol 1996;19:863–867PubMedGoogle Scholar
  12. 12.
    Böhm A, Pintér A, Préda I. QT dependent T wave sensing. Pacing Clin Electrophysiol 1998;21:1290–1291Google Scholar
  13. 13.
    Cossu SF, Hsia HH, Simson MB, Hana MS, Clyne CA. Inappropriate pauses during bradycardia pacing in a third-generation implantable cardioverter defibrillator. Pacing Clin Electrophysiol 1997;20:2271–2274PubMedGoogle Scholar
  14. 14.
    Wilkoff BL, Ching EA, Chung MK, et al. Dual chamber pacemaker defibrillators: a unique form of crosstalk inhibition. Pacing Clin Electrophysiol 1998;21:847 (Abstract)Google Scholar
  15. 15.
    Coppess MA, Miller JM, Zipes DP, Groh WJ. Software error resulting in malfunction of an implantable cardioverter-defibrillator. J Cardiovasc Electrophysiol 1999;10:871–873PubMedGoogle Scholar
  16. 16.
    De Vries DW. Medical device safety alert. Guidant Corporation, December 4, 1998.Google Scholar
  17. 17.
    Tremmel J. Important patient management information. Medtronic, Inc. October 15, 1999Google Scholar
  18. 18.
    Guarnieri T, Datorre SD, Bondke H, Brinker J, Myers S Levine JH. Increased pacing threshold after an automatic defibrillator shock in dogs: effects of class I and class II antiarrhythmic drugs. Pacing Clin Electrophysiol 1988;11:1324–1330PubMedGoogle Scholar
  19. 19.
    Kudenchuk PJ, Poole JE, Dolack GL, Gleva MJ, Anderson J, Troutman C, Bardy GH. Prospective evaluation of the effect of biphasic waveform defibrillation on ventricular pacing thresholds. J Cardiovasc Electrophysiol 1997;8:485–495PubMedGoogle Scholar
  20. 20.
    Welch PJ, Joglar JA, Hamdan MH, Nelson L, Page RL. The effect of biphasic defibrillation on the immediate pacing threshold of a dedicated bipolar, steroid-eluting lead. Pacing Clin Electrophysiol 1999;22:1229–1233PubMedGoogle Scholar
  21. 21.
    Kessler DJ, Canby RC, Horton RP, Joglar JA, Jessen ME, Page RL. Effect of biphasic endocardial countershock on pacing thresholds in humans. Am J Cardiol 1996;77:527–528PubMedGoogle Scholar
  22. 22.
    Sticherling C, Strickberger SA, Michaud GF. Unique interaction between an atrial single-chamber pacemaker and a ventricular defibrillator. J Intery Card Electtrophysiol 2000;4:241–244Google Scholar
  23. 23.
    Pinski SL, Fahy GJ. The proarrhythmic potential of implantable defibrillators. Circulation 1995;92:1651–1664PubMedGoogle Scholar
  24. 24.
    Winkle RA, Bach Jr SM, Mead RH, Gaudiani VA, Stinson EB, Fain ES, Schmidt P. Comparison of defibrillation efficacy in humans using a new catheter and superior vena cava spring-left ventricular patch electrodes. J Am Coll Cardiol 1988;11:365–370PubMedGoogle Scholar
  25. 25.
    Epstein AE, Plumb VJ, Kirk KA, Kay GN. Pacing threshold increase in nonthoracotomy implantable defibrillator leads: implications for battery longevity and margin of safety. J Interven Card Electrophysiol 1997:1:131–134Google Scholar
  26. 26.
    Epstein AE, Kay GN, Plumb VJ, Daily SM, Anderson PG. Gross and microscopic pathological changes associated with nonthoracotomy implantable defibrillator leads. Circulation 1998;1517–1524Google Scholar
  27. 27.
    Ehrlich S, Rashtian M, Kwasney J, et al. Improved sensing and pacing characteristics utilizing steroid eluting active fixation transvenous defibrillator leads: a randomized trial. Pacing Clin Electrophysiol 1999;22:869 (Abstract)Google Scholar
  28. 28.
    Weber M, Bäcker D, Bansch D, Brunn J, Castrucci M, Gradaus R, Breithardt G, Block M. Efficacy and safety of the initial use of stability and onset criteria in implantable cardioverter defibrillators. J Cardiovasc Electrophysiol 1999; 10: 145–153PubMedGoogle Scholar
  29. 29.
    Nanthakumar K, Paquette M, Newman D, Deno DC, Malden L, Gunderson B, Gilkerson J, Greene M, Heng D, Dorian P. Inappropriate therapy from atrial fibrillation and sinus tachycardia in automated implantable cardioverter-defibrillators. Am Heart J 2000;139:797–803PubMedGoogle Scholar
  30. 30.
    Barold H, Newby K, Tomassoni G, Kearny M, Brandon J, Natale A. Prospective evaluation of new and old criteria to discriminate between supraventricular and ventricular tachycardia in implantable defibrillators. Pacing Clin Electrophysiol 1998; 21:1347–1355PubMedGoogle Scholar
  31. 31.
    Brugada J, Mont L, Figueiredo M, Matas M, Navarro-Lopez F. Enhanced detection criteria in implantable defibrillators. J Cardiovasc Electrophysiol 1998; 9: 261–268PubMedGoogle Scholar
  32. 32.
    Swerdlow CD, Ahem T, Chen PS, Hwang C, Gang E, Mandel W, Kass RM, Peter CT. Underdetection of ventricular tachycardia by algorithms to enhance specificity in a tiered therapy cardioverter defibrillator. J Am Coll Cardiol 1994;24:416–424PubMedGoogle Scholar
  33. 33.
    Kühlkamp V, Dornberger V, Mewis C, Suchalla R, Bosch RF, Seipel L. Clinical experience with the new detection algorithms for atrial fibrillation of a defibrillator with dual chamber pacing and sensing. J Cardiovasc Electrophysiol 1999; 10: 905–915PubMedGoogle Scholar
  34. 34.
    Dorian P, Newman D, Thibault B, et al. A randomized clinical trial of a standardized protocol for the prevention of inappropriate therapy using a dual chamber implantable cardioverter-defibrillator. Circulation 1999;100:1–786 (Abstract)Google Scholar
  35. 35.
    Wilkoff B, Gillberg J, Hillman S et al. Clinical experience with detection of spontaneous ventricular arrhythmias by a new dual chamber defibrillator in a multicenter study. Circulation 1998; 98:1–289 (Abstract)Google Scholar
  36. 36.
    Jung W, Henry C, Wolpert C, et al. Influence of tachycardia rate on the performance of a new dual chamber implantable cardioverter-defibrillator detection algorithm. Pacing Clin Electrophysiol 2000;23:572 (Abstract)Google Scholar
  37. 37.
    Jones GK, Bardy GH. Considerations for ventricular fibrillation detection by implantable cardioverter defibrillators. Am Heart J 1994;127:1107–1110PubMedGoogle Scholar
  38. 38.
    Bramwell DA, Kroll K, Lehmann MH. The amplifier: sensing the depolarization. In: Implantable cardioverter-defibrillator therapy: the engineering-clinical interface. Kroll MW, Lehmann MH, eds. Norwell, Massachusetts: Kluwer Academical Publishers, 1996, p. 275–302Google Scholar
  39. 39.
    Degeratu FT, Khalighi K, Peters RW, Shorofsky SR, Gold MR. Sensing lead failure in implantable defibrillators: a comparison of two commonly used leads. J Cardiovasc Electrophysiol 2000;11:21–24PubMedGoogle Scholar
  40. 40.
    Mera F, DeLurgio DB, Langberg JJ, Moss EA, Leon A. Transvenous cardioverter defibrillator lead malfunction due to terminal connector damage in pectoral implants. Pacing Clin Electrophysiol 1999;22:1797–1801PubMedGoogle Scholar
  41. 41.
    Rosenthal ME, Paskman C. Noise detection during bradycardia pacing with a hybrid nonthoracotomy implantable cardioverter-defibrillator system: incidence and clinical significance. Pacing Clin Electrophysiol 1998;21:1380–1386PubMedGoogle Scholar
  42. 42.
    Mann DE, Otto L, Kelly PA, Reiter MJ. Effect of sensing system on the incidence of myopotential oversensing during bradycardia pacing in implantable cardioverterdefibrillators. Am J Cardiol 2000;85:1380–1382PubMedGoogle Scholar
  43. 43.
    Swygman CA, Sloan SB, Homoud MK, et al. Oversensing of diaphragmatic myopotentials by implantable cardioverter-defibrillators: a unique cause of inappropriate therapy and inhibition of pacing. Pacing Clin Electrophysiol 1998;21:810 (Abstract)Google Scholar
  44. 44.
    Deshmukh P, Anderson K. Myopotential sensing by a dual chamber implantable cardioverter-defibrillator: two case reports. J Cardiovasc Electrophysiol 1998;9:767–772PubMedGoogle Scholar
  45. 45.
    Peters RW, Cooklin M, Brockman R, Shorofsky SR, Gold MR. Inappropriate shocks from implanted cardioverter defibrillators caused by sensing of diaphragmatic myopotentials. J Intery Card Electrophysiol 1998;2:367–370Google Scholar
  46. 46.
    Babuty D, Fauchier L, Cosnay P. Inappropriate shocks delivered by implantable cardioverter-defibrillators during oversensing of activity of diaphragmatic muscle. Heart 1999;81:94–96PubMedGoogle Scholar
  47. 47.
    Sweeney MO, Ellison KE, Shea JB. Spontaneous and provoked diaphragmatic myopotential oversensing in patients with ICDs: incidence and relationship to clinical variables, sensing lead configuration and sensing algorithms. J Am Coll Cardiol 1999;33:142A (Abstract)Google Scholar
  48. 48.
    Kopp DE, Burke MC, Lin AC, et al. Oversensing in dual chamber implantable cardioverter-defibrillators. Pacing Clin Electrophysiol 2000;23:591 (Abstract)Google Scholar
  49. 49.
    Callans DJ, Hook BG, Kleiman RB, Mitra RL, Flores BT, Marchlinski FE. Unique sensing errors in third-generation implantable cardioverter-defibrillators. J Am Coll Cardiol 1993;22:1135–1140PubMedGoogle Scholar
  50. 50.
    Singer I, DeBorde R, Veltri E, Siddoway L, Griffith L, Levine J, Guamieri T. The automatic implantable cardioverter defibrillator: T wave sensing in the newest generation. Pacing Clin Electrophysiol 1988;11:1584–91PubMedGoogle Scholar
  51. 51.
    Curwin JH, Roelke M, Ruskin IN. Inhibition of bradycardia pacing caused by far-field atrial sensing in a third-generation cardioverter defibrillator with an automatic gain feature. Pacing Clin Electrophysiol 1996;19:124–126PubMedGoogle Scholar
  52. 52.
    Schecter SO, Greenberg SM, Hoch DH, Cesa M, Levine JH. Inappropriate discharges of an implantable cardioverter defibrillator secondary to automatic adjustable gain of atrial tachycardia. Pacing Clin Electrophysiol 1997;20:1721–1722PubMedGoogle Scholar
  53. 53.
    Peters W, Kowallik P, Wittenberg G, Scholl C, Meesmann M. Inappropriate discharge of an implantable cardioverter-defibrillator during atrial flutter and intermittent ventricular antibradycardia pacing. J Cardiovasc Electrophysiol 1997;8:1167–1174PubMedGoogle Scholar
  54. 54.
    Bocchiardo M, Padeletti L, Scaglione M, et al. Implantable cardioverter-defibrillators with biventricular pacing in patients with congestive heart failure. Pacing Clin Electrophysiol 2000;23:569 (Abstract)Google Scholar
  55. 55.
    Pinski SL, Trohman RG. Interference with cardiac pacing. Cardiol Clin 2000;18:219239Google Scholar
  56. 56.
    Fetter JG, Benditt DG, Stanton MS. Electromagnetic interference from welding and motors on implantable cardioverter-defibrillators as tested in the electrically hostile work site. J Am Coll Cardiol 1996;28:423–427PubMedGoogle Scholar
  57. 57.
    Madrid A, Sanchez A, Bosch E, Femandez E, Moro-Serrano C. Dysfunction of implantable defibrillators caused by slot machines. Pacing Clin Electrophysiol 1997;20:212–214PubMedGoogle Scholar
  58. 58.
    Man KC, Davidson T, Langberg JJ, Morady F, Kalbfleisch SJ. Interference from a hand held radiofrequency remote control causing discharge of an implantable defibrillator. Pacing Clin Electrophysiol 1993;16:1756–1758PubMedGoogle Scholar
  59. 59.
    Glotzer TV, Gordon M, Sparta M, Rodoslovich G, Zimmerman J. Electromagnetic interference from a muscle stimulation device causing discharge of an implantable cardioverter defibrillator: epicardial bipolar and endocardial bipolar sensing circuits are compared. Pacing Clin Electrophysiol 1998;21:1996–1998PubMedGoogle Scholar
  60. 60.
    Philbin DM, Marieb MA, Aithal KH, Scoenfeld MH. Inappropriate shocks delivered by an ICD as a result of sensed potentials from a transcutaneous electronic nerve stimulation unit. Pacing Clin Electrophysiol 1998;21:2010–2011PubMedGoogle Scholar
  61. 61.
    McIvor ME. Environmental electromagnetic interference from electronic article surveillance devices: interactions with an ICD. Pacing Clin Electrophysiol 1995;18:2229–2230PubMedGoogle Scholar
  62. 62.
    Mathew P, Lewis C, Neglia J, Krol RB, Saksena S. Interaction between electronic article surveillance systems and implantable defibrillators: insights from a fourth generation ICD. Pacing Clin Electrophysiol 1997;20:2857–2859PubMedGoogle Scholar
  63. 63.
    Santucci PA, Haw J, Trohman RG, Pinski SL. Interference with an implantable defibrillator by an electronic antitheft-surveillance device. N Engl J Med 1998;339:1371–1374PubMedGoogle Scholar
  64. 64.
    Groh W, Boschee S, Engelstein E, Miles WM, Burton ME, Foster RR, Crevey BJ, Zipes DP. Interactions between electronic article surveillance systems and implantable cardioverter-defibrillators. Circulation 1999;100:387–392PubMedGoogle Scholar
  65. 65.
    Fetter JG, Ivans V, Benditt DG, Collins J. Digital cellular telephone interaction with implantable cardioverter-defibrillators. J Am Coll Cardiol 1998;31:623–628PubMedGoogle Scholar
  66. 66.
    Bassen HI, Moore HJ, Ruggera PS. Cellular phone interference testing of implantable cardiac defibrillators in vitro. Pacing Clin Electrophysiol 1998;21:1709–1715PubMedGoogle Scholar
  67. 67.
    Jiménez A, Hernández Madrid A, Pascual J, Gonzalez-Rebello JM, Fernandez E, Sanchez A, Ortega J, Lonzano F, Munoz R, Moro C. Interferencias electromagnéticas entre los desfibriladores automáticos y los teléfonos móviles digitales y analógicos. Rev Esp Cardiol 1998;51:375–382PubMedGoogle Scholar
  68. 68.
    Radiofrequency interference with medical devices. A technical information statement. IEEE Eng Med Biol Mag 1998;17:111–114Google Scholar
  69. 69.
    Sanmart—n M, Fernández Lozano I, Márquez J, Antorrena I, Bautista A, Silva L, Ortigosa J, de Artaza M. Ausencia de interferencia entre teléfonos móviles GSM y desfibriladores implantables: estudio in-vivo. Rev Esp Cardiol 1997;50:715–719Google Scholar
  70. 70.
    Gold MR, Olsovsky MR, Pelini MA, Peters RW, Shorofsky SR. Comparison of single and dual-coil active pectoral defibrillation lead systems. J Am Coll Cardiol 1998;31:1391–1394PubMedGoogle Scholar
  71. 71.
    Wolfhard UF, Jäger HP, Knocks M, Doetsch N. Alternative lead positioning in the right ventricular outflow tract in transvenous implantation of ICDs. Pacing Clin Electrophysiol 1995;18:179–181PubMedGoogle Scholar
  72. 72.
    Giudici MC, Paul DL, VanWhy KJ. Permanent right ventricular outflow septal placement of active-fixation pacing-defibrillation leads: safety and efficacy for pacing and defibrillation. Pacing Clin Electrophysiol 1999;22:801 (Abstract)Google Scholar
  73. 73.
    Taneja T, Goldberger J, Parker MA, Johnson D, Robinson M, Horvath G, Kadish AH. Reproducibility of ventricular fibrillation characteristics in patients undergoing implantable cardioverter-defibrillator implantation. J Cardiovasc Electrophysiol 1997;8:1209–1217PubMedGoogle Scholar
  74. 74.
    Bollmann A, Langberg JJ. The relationship between induced and spontaneous ventricular fibrillation. Circulation 1997;96:1–529 (Abstract)Google Scholar
  75. 75.
    Hurwitz JL, Hook BG, Flores BT, Marchlinski FE. Importance of abortive shock capability with electrogram storage in cardioverter-defibrillator devices. J Am Coll Cardiol 1993;21:895–900PubMedGoogle Scholar
  76. 76.
    Mann DE, Kelly PA, Reiter MJ. Inappropriate shock therapy for nonsustained ventricular tachycardia in a dual chamber pacemaker defibrillator. Pacing Clin Electrophysiol 1998;21:2005–2006PubMedGoogle Scholar
  77. 77.
    Kim S, Ling J, Fisher J, Wang R, Rameneni A, Roth JA, Ferrik KJ, Gross J, Ben-Zur U, Brodman R. Comparison and frequency of ventricular arrhythmias after defibrillator implantation by thoracotomy versus non thoracotomy approaches. Am J Cardiol 1994; 74: 1245–1248PubMedGoogle Scholar
  78. 78.
    Exner D, Pinski SL, Wyse GD, Renfroe EG, Follmann D, Gold M, Beckman KJ, Coromilas J, Lancaster S, Hallstrom AP. Electrical storm presages non-arrhythmic death: The Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial. Circulation 2001;103:2066–2071PubMedGoogle Scholar
  79. 79.
    Credner S, Klingenheben T, Mauss O, Sticherling C, Hohnloser SH. Electrical storm in patients with transvenous implantable cardioverter-defibrillators. J Am Coll Cardiol 1998; 32:1909–1915PubMedGoogle Scholar
  80. 80.
    Villacastin J, Almendral J, Arenal A. Incidence and clinical significance of multiple, consecutive, appropriate, high-energy discharges in patients with implanted cardioverter-defibrillators. Circulation 1996; 93:753–762PubMedGoogle Scholar
  81. 81.
    Pacifico A, Ferlic L, Cedillo-Salazar F, Nasir N Jr., Doyle TK, Henry PD. Shocks as predictors of survival in patients with cardioverter-defibrillators. J Am Coll Cardiol 1999;34:204–210PubMedGoogle Scholar
  82. 82.
    Li H, Natale A, Zhu W, Greenfield RA, Easley A, Barrington W, Windle J. Causes and complications of discontinuation of the implantable cardioverter-defibrillator therapy in non terminally ill patients. Am J Cardiol 1998; 81: 1203–1205PubMedGoogle Scholar
  83. 83.
    De Ferrari GM, Landolina M, Mantica M, Manfredini R, SchwartzPJ, Lotto A. Baroreflex sensitivity, but not heart rate variability, is reduced in patients with life threatening ventricular arrhythmias long after myocardial infarction. Am Heart J 1995; 130: 473–480PubMedGoogle Scholar
  84. 84.
    Pires L, Lehmann MH, Steinman RG, Bagga JJ, Schuger CD. Sudden death in implantable cardioverter-defibrillator recipients: clinical context, arrhythmic events and device responses. J Am Coll Card 1999;33: 24–32Google Scholar
  85. 85.
    Schmitt C, Brachmann J, Waldecker B, Navarrete B, Beyer T, Pfeifer A, Kübler W. Implantable cardioverter defibrillator: possible hazards of electromagnetic interference. Pacing Clin Electrophysiol 1991;14:982–984PubMedGoogle Scholar
  86. 86.
    Karson TH, Grace K, Denes P. Stereo speaker silences automatic implantable cardioverter-defibrillator. N Engl J Med 1989;320:1628 (Letter)PubMedGoogle Scholar
  87. 87.
    Ferrick KJ, Johnston D, Kim SG, Roth J, Brodman RF, Gross GN, Furman S. Inadvertent AICD inactivation while playing bingo. Am Heart J 1991;121:206–207PubMedGoogle Scholar
  88. 88.
    Pinski SL, Arnold AZ, Mick M, Maloney JD, Trohman RG. Safety of external cardioversion/defibrillation in patients with internal defibrillation patches and no device. Pacing Clin Electrophysiol 1991; 14:7–12PubMedGoogle Scholar
  89. 89.
    Waldecker B, Brugada P, Zehender M, Stevenson W, den Dulk K, Wellens HJJ. Importance of modes of electrical termination of ventricular tachycardia for the selection of implantable antitachycardia devices. Am J Cardiol 1986;57:150–155PubMedGoogle Scholar
  90. 90.
    Roseqvist M. Antitachycardia pacing: which patients and which methods? Am J Cardiol 1996;78 (Suppl 5A):92–97Google Scholar
  91. 91.
    Cook JR, Kirchhoffer JB, Fitzgerald TF, Lajzer DA. Comparison of decremental and burst overdrive pacing as treatment for ventricular tachycardia associated with coronary artery disease. Am J Cardiol 1992;70:311–315PubMedGoogle Scholar
  92. 92.
    Gillis AM, Leitch JW, Sheldon RS, Morillo CA, Wyse DG, Yee R, Klein GJ, Mitchell LB. A prospective randomized comparison of autodecremental pacing to burst pacing in device therapy for chronic ventricular tachycardia secondary to coronary artery disease. Am J Cardiol 1993;72:1146–1151PubMedGoogle Scholar
  93. 93.
    Calkins H, el-Atassi R, Kalbfleisch S, Langberg J, Morady F. Comparison of fixed burst versus decremental burst pacing for termination of ventricular tachycardia. Pacing Clin Electrophysiol. 1993;16:26–32PubMedGoogle Scholar
  94. 94.
    Newman D, Dorian P, Hardy J. Randomized controlled comparison of antitachycardia pacing algorithms for termination of ventricular tachycardia. J Am Coll Cardiol 1993;21:1413–1418PubMedGoogle Scholar
  95. 95.
    Ip JH, Winters SL, Schweitzer P, Lotvin A, Tepper D, Gomes AJ. Determinants of pace-terminable ventricular tachycardia: implications for implantable antitachycardia devices. Pacing Clin Electrophysiol 1991;14:1777–1781PubMedGoogle Scholar
  96. 96.
    Keren G, Miura DS, Somberg JC. Pacing termination of ventricular tachycardia: influence of antiarrhythmic-slowed ectopic rate. Am Heart J 1984;107:638–643PubMedGoogle Scholar
  97. 97.
    Heisel A, Neuzner J, Himmrich E, Pitschner HF, Liebrich A, Jung J, Heisel A. Safety of antitachycardia pacing in patients with implantable cardioverter-defibrillators and severely depressed left ventricular function. Pacing Clin Electrophysiol 1995;18:137–141PubMedGoogle Scholar
  98. 98.
    Nasir N, Pacifico A, Doyle TK, Earle NR, Hardage ML, Henry PD. Spontaneous ventricular tachycardia treated by antitachycardia pacing. Am J Cardiol 1997;79:820–822PubMedGoogle Scholar
  99. 99.
    Monahan KM, Hadjis T, Hallett N, Casavant D, Josephson ME. Relation of induced to spontaneous ventricular tachycardia from analysis of stored far-field implantable defibrillator electrograms. Am J Cardiol 1999;83:349–353PubMedGoogle Scholar
  100. 100.
    Lampert R, Jain D, Burg MM, Batsford MM, McPherson CA. Destabilizing effects of mental stress on ventricular arrhythmias in patients with implantable cardioverterdefibrillators. Circulation 2000;101:158–164PubMedGoogle Scholar
  101. 101.
    Fries R, Heisel A, Nikoloudakis N, Jung J, Schafers HJ, Schafers HJ, Schieffer H. Antitachycardia pacing in patients with implantable cardioverter-defibrillators: inverse circadian variation of therapy success and acceleration. Am J Cardiol 1997;80:1487–1489PubMedGoogle Scholar
  102. 102.
    Mont L, Valentino M, Sambola A, Matas M, Aguinaga L, Brugada J. Arrhythmia recurrence in patients with a healed myocardial infarction who received an implantable defibrillator: analysis according to the clinical presentation. J Am Coll Cardiol 1999;34:351–357PubMedGoogle Scholar
  103. 103.
    Exner DV, Gillis AM, Sheldon RS, Wyse DG, Duff HJ, Cassidy PR, Mitchell LB. Telemetry-documented, pace-terminable ventricular tachycardia in patients with ventricular fibrillation. Am J Cardiol 1998;81:235–238PubMedGoogle Scholar
  104. 104.
    Schaumann A, von zur Mühlen F, Herse B, Gonka BD, Freuzer H. Empirical versus tested antitachycardia pacing in implantable cardioverter defibrillators: a prospective study including 200 patients. Circulation 1998;97:66–74PubMedGoogle Scholar
  105. 105.
    Mc Veigh K, Mower MM, Nisam S, Voshage L. Clinical efficacy of low energy cardioversion in automatic implantable cardioverter-defibrillator patients. Pacing Clin Electrophysiol 1991;14:1846–1850Google Scholar
  106. 106.
    Lauer MR, Young C, Liem LB, Ottoboni L, Peterson J, Goold P, Sung RG. Ventricular fibrillation induced by low-energy shocks from programmable implantable cardioverter-defibrillators in patients with coronary artery disease. Am J Cardiol 1994;73:559–563PubMedGoogle Scholar
  107. 107.
    Bardy GH, Poole JE, Kudenchuk PJ, Dolack GL, Mehre R, DeGroot P, Raitt MH, Jones JK, Johnson G. A prospective randomized repeat cross-over comparison of antitachycardia pacing with low-energy cardioversion. Circulation 1993;87:1889–96PubMedGoogle Scholar
  108. 108.
    McClelland JH, Daubert JP, Kavanagh KM, Harrell FE Jr, Ideker RE. High and low strength nonsynchronized shocks given during canine ventricular tachy-cardia. Pacing Clin Electrophysiol. 1992;15:986–992PubMedGoogle Scholar
  109. 109.
    Perelman MS, Rowland E, Krikler DM. Assessment of a prototype implantable cardioverter for ventricular tachycardia: relation between synchronization of sensing and origin of the tachycardia. Br Heart J 1984;52:385–391PubMedGoogle Scholar
  110. 110.
    Jackman WM, Zipes DP. Low-energy synchronous cardioversion of ventricular tachycardia using a catheter electrode in a canine model of subacute myocardial infarction. Circulation 1982;66:187–195PubMedGoogle Scholar
  111. 111.
    Li HG, Yee R, Mehra R, DeGroot P, Klein GJ, Zardini M, Thakur RK, Morillo CA. Effect of shock timing on efficacy and safety of internal cardioversion for ventricular tachycardia. J Am Coll Cardiol 1994;24:703–708PubMedGoogle Scholar
  112. 112.
    Chinushi M, Aizawa Y, Higuchi K. Ventricular tachycardia initiated by high energy cardioversion in a patient with an implantable cardioverter-defibrillator. Heart 1997;77:373–374PubMedGoogle Scholar
  113. 113.
    Zivin A, Souza J, Pelosi F, Flemming M, Knight BP, Gyoal R, Morady F, Strickberger SA. Relationship between shock energy and post defibrillation ventricular arrhythmias in patients with implantable defibrillators. J Cardiovasc Electrophysiol 1999;10:370–377PubMedGoogle Scholar
  114. 114.
    Katz A, Sweeney RJ, Gill RM, Reid RR, Prystoesky EN. Relation of atrial refractoriness to upper and lower limits of vulnerability for atrial fibrillation/flutter following implantable ventricular defibrillator shocks. Circulation 1999;100:1125–1130PubMedGoogle Scholar
  115. 115.
    Katz A, Evans JJ, Fogel RI, Schier JJ, Matheny RG, Baranowski GM, Prystowsky EN. Atrial fibrillation/flutter induced by implantable ventricular defibrillator shocks: difference between epicardial and endocardial energy delivery. J Cardiovasc El ectrophysiol 1997:8:35–41Google Scholar
  116. 116.
    Florin TJ, Weiss DN, Peters RW, Shorofsky SR, Gold MR. Induction of atrial fibrillation with low-energy defibrillator shocks in patients with implantable cardioverter-defibrillators. Am J Cardiol 1997;80:960–962PubMedGoogle Scholar
  117. 117.
    Birgersdotter-Green U, Rosenqvist M, Lindemans FW, Rydén L, Rádegran K. Holier documented sudden death in a patient with an mplanted defibrillator. Pacing Clin Electrophysiol 1992;15:1008–1014PubMedGoogle Scholar
  118. 118.
    Swerdlow CD, Schsls W, Dijkman B, Jung W, Sheth NV, Olson WH, Gunderson BD. Detection of atrial fibrillation and flutter by a dual-chamber implantable cardioverterdefibrillator. Circulation 2000;101:878–885PubMedGoogle Scholar
  119. 119.
    Ayers GM, Alferness CA, Ilina M, Wagner DO, Sirokman WA, Adams JM, Griffin GC. Ventricular proarrhythmic effects of ventricular cycle length and shock strength in a sheep model of transvenous atrial defibrillation. Circulation 1994;89:413–422PubMedGoogle Scholar
  120. 120.
    Simons GR, Newby KH, Kearney MM, Brandon MJ, Natale A. Safety of transvenous low energy cardioversion of atrial fibrillation in patients with a history of ventricular tachycardia: effects of rate and repolarization time on proarrhythmic risk. Pacing Clin Electrophysiol 1998;21:430–437PubMedGoogle Scholar
  121. 121.
    Sra JS, Maglio C, Dhala A, Blank Z, Biehl M, Deshpande S, Keelan ET, Jazayeri MR, Akhter M. Feasibility of atrial fibrillation detection and use of a preceding synchronization interval as a criterion for shock delivery in humans with atrial fibrillation. J Am Coll Cardiol 1996;28:1532–1538PubMedGoogle Scholar
  122. 122.
    Jung W, Wolpert C, Esmailzadeh B, Spehl S, Herwig S, Schumacher B, Lewalter T, Omran H, Vahlhaus C, Weiz A, Luderitz B. Clinical experience with implantable atrial and combined atrioventricular defibrillators. J Intery Card Electrophysiol 2000;4(Suppl 1):185–195Google Scholar
  123. 123.
    Wiggers CJ, Wegria R. Ventricular fibrillation due to single localized induction and condenser shocks applied during the vulnerable phase of ventricular systole. Am J Physiol. 1940;128:500–505Google Scholar
  124. 124.
    Moore EN, Spear JF. Ventricular fibrillation threshold. Arch Intern Med 1975;135:446–453PubMedGoogle Scholar
  125. 125.
    Chen PS, Shibata N, Dixon EG, Martin RO, Ideker RE. Comparison of the defibrillation threshold and the upper limit of vulnerability. Circulation 1986;73:10221028Google Scholar
  126. 126.
    Hwang C, Swerdlow CD, Kass RM, Gang ES, Mandel WJ, Peter CT, Chen PS. Upper limit of vulnerability reliably predicts the defibrillation threshold in humans. Circulation 1994;90:2308–2314PubMedGoogle Scholar
  127. 127.
    Han J, Garcia de Jalon PD, Moe GK. Adrenergic effects on ventricular vulnerability. Circ Res 1964;14:516–524PubMedGoogle Scholar
  128. 128.
    Han J. Ventricular vulnerability during acute coronary occlusion. Am J Cardiol 1969;24:857–864PubMedGoogle Scholar
  129. 129.
    Gottlieb C, Rosenthal M, Marchlinski FE. Initiation of sustained ventricular arrhythmia resulting from R wave-synchronous AICD discharge. Am Heart J 1988;115:915–917PubMedGoogle Scholar
  130. 130.
    Kou WH, Kirsh MM, Stirling MC, Kadish AH, Orringer CA, Morady F. Provocation of ventricular tachycardia by an automatic implantable cardioverter defibrillator. Am Heart J 1990;120:208–210PubMedGoogle Scholar
  131. 131.
    Wolpert C, Jung W, Scholl C, Spehl S, Cyran J, Lüderitx B. Electrical proarrhythmia: induction of inappropriate atrial therapies due to far-field R wave oversensing in a new dual chamber defibrillator. J Cardiovasc Electrophysiol 1998;9:859–863PubMedGoogle Scholar
  132. 132.
    Weretka S, Becker R, Hilbel T, et al. Far-field R wave oversensing in new dual chamber ICDs: incidence, predisposing factors, and clinical implications. Pacing Clin Electrophysiol 2000;23:571 (Abstract)Google Scholar
  133. 133.
    Bilitch M, Cosby RS, Cafferky EA. Ventricular fibrillation and competitive pacing. NEngl J Med 1967; 276:598–604Google Scholar
  134. 134.
    Saeed M, Mahapatra S, Mouded M, et al. Initiation of ventricular tachycardia: analysis of intracardiac electrograms in patients with internal cardioverter defibrillator. J Am Coll Cardiol 1999;33:118A (Abstract)Google Scholar
  135. 135.
    Callans DJ, Hook BG, Marchlinski FE. Effect of rate and coupling interval on endocardial R wave amplitude variability in permanent ventricular sensing lead systems. J Am Coll Cardiol 1993;22:746–750PubMedGoogle Scholar
  136. 136.
    Brewer JE, Perttu JS, Kroll MW, Donohoo AM. Dual level sensing significantly improves automatic threshold control for R wave sensing in implantable defibrillators. Pacing Clin Electrophysiol 1996;19:2051–2059PubMedGoogle Scholar
  137. 137.
    Callans DJ, Hook BG, Marchlinski FE. Paced beats following single nonsensed complexes in a “codependent” cardioverter defibrillator and bradycardia pacing system: potential for ventricular tachycardia induction. Pacing Clin Electrophysiol 1991;14:1281–1287PubMedGoogle Scholar
  138. 138.
    Carpeneter CM, Galvin J, Guy M, McGovern BA. Runaway pacemaker in an implantable cardioverter-defibrillator. J Cardiovasc Electrophysiol 1998;9:1008–1011Google Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • Stephen Pavia
    • 1
  • Sergio L. Pinski
    • 2
  • Andrea Natale
    • 1
  1. 1.The Cleveland Clinic FoundationClevelandUSA
  2. 2.Rush-Presbyterian-St. Luke’s Medical CenterChicagoUSA

Personalised recommendations